Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CKPT

Checkpoint Therapeutics (CKPT) Stock Price, News & Analysis

Checkpoint Therapeutics logo

About Checkpoint Therapeutics Stock (NASDAQ:CKPT)

Advanced Chart

Key Stats

Today's Range
$4.26
$4.26
50-Day Range
$4.15
$4.29
52-Week Range
$2.06
$4.50
Volume
N/A
Average Volume
1.56 million shs
Market Capitalization
$370.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.33
Consensus Rating
Hold

Company Overview

Checkpoint Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

CKPT MarketRank™: 

Checkpoint Therapeutics scored higher than 6% of companies evaluated by MarketBeat, and ranked 921st out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Checkpoint Therapeutics has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Checkpoint Therapeutics has received no research coverage in the past 90 days.

  • Read more about Checkpoint Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Checkpoint Therapeutics is -2.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Checkpoint Therapeutics is -2.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Checkpoint Therapeutics' valuation and earnings.
  • Short Interest

    There is no current short interest data available for CKPT.
  • Dividend Yield

    Checkpoint Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Checkpoint Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CKPT.
  • Search Interest

    2 people have searched for CKPT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Checkpoint Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Checkpoint Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 22.00% of the stock of Checkpoint Therapeutics is held by institutions.

  • Read more about Checkpoint Therapeutics' insider trading history.
Receive CKPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CKPT Stock News Headlines

Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Checkpoint Therapeutics Announces Merger Progress
See More Headlines

CKPT Stock Analysis - Frequently Asked Questions

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.09.

Checkpoint Therapeutics's stock reverse split before market open on Sunday, December 4th 2022.The 1-10 reverse split was announced on Sunday, December 4th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 4th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Checkpoint Therapeutics investors own include TG Therapeutics (TGTX), Bionano Genomics (BNGO), Fortress Biotech (FBIO), NIO (NIO), uniQure (QURE), VBI Vaccines (VBIV) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/13/2025
Today
7/26/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CKPT
CIK
1651407
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$4.80
Low Price Target
$4.10
Potential Upside/Downside
+1.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$51.85 million
Net Margins
N/A
Pretax Margin
-98,868.08%
Return on Equity
N/A
Return on Assets
-659.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.29
Quick Ratio
0.29

Sales & Book Value

Annual Sales
$41 thousand
Price / Sales
9,041.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.47) per share
Price / Book
-9.06

Miscellaneous

Outstanding Shares
87,020,000
Free Float
47,808,000
Market Cap
$370.71 million
Optionable
Optionable
Beta
1.18
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:CKPT) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners